Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M Rosario Chica-Parrado"'
Autor:
M Rosario Chica-Parrado, Chang-Ching Lin, Timothy Mahoney, Elizabeth Mauer, Ariella Hanker, Carlos Arteaga
Publikováno v:
Cancer Research. 83:P5-02
Background CDK4/6 inhibitors (CDK4/6i), like palbociclib, ribociclib, and abemaciclib, along with antiestrogens, have revolutionized treatment for ER+/HER2- metastatic breast cancer (MBC). Although most patients initially respond, almost all eventual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f97b8e7406a4c137ac0578219480c3
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-02
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-02
Autor:
Alicia Garrido Aranda, Begoña Bermejo, Johannes Fredebohm, Estefania Bellagarza, Frank Holtrup, Maria Jose Lozano, Emilio Alba, Vanessa de Luque, Begona Jimenez Rodriguez, Ana Lluch Hernandez, M Rosario Chica Parrado, Luis Vicioso, Mar Moreno Ros, Martina Alvarez, Gema Diaz Córdoba, Cristina Hernando, Daniel Mehnert, Annette Nocon, Frederick S. Jones, Matthew B. Ryder
Publikováno v:
Journal of Clinical Oncology. 36:12073-12073
12073Background: Mammography is the current standard of care for breast cancer(BC) screening. However, not all cancers are detectable on mammography and not all mammographic findings represent canc...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7de79aae9f06d0ce7016ff6449add9f5
https://doi.org/10.1200/jco.2018.36.15_suppl.12073
https://doi.org/10.1200/jco.2018.36.15_suppl.12073
Autor:
Ana Isabel Lavado Fernandez, Cristina Fernandez-Sousa, Vanessa de Luque, Elisabeth Perez Ruiz, Nuria Ribelles, Pedro Sánchez Rovira, C González-Hermoso, Sean Ferree, Luis Vicioso, Arthur Jeiranian, Aleix Prat, Martina Alvarez, Emilio Alba, Begona Jimenez Rodriguez, Cesar Ramirez Tortosa, Angela Santonja, Wesley Buckingham, Naeem Dowidar, M Rosario Chica Parrado, Carl Schaper
Publikováno v:
Journal of Clinical Oncology. 33:569-569
569 Background: Pathological complete response following NAC is associated with improved survival. CESP is a novel algorithm derived from the GEICAM 2006-03 clinical trial which is based on the ass...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4113ee6e43167e7f039fb7f301cfd6ec
https://doi.org/10.1200/jco.2015.33.15_suppl.569
https://doi.org/10.1200/jco.2015.33.15_suppl.569